$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[미국특허] Controlled release drug suspension delivery device 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/24
  • A61K-009/32
  • A61K-009/36
출원번호 US-0363451 (1994-12-22)
발명자 / 주소
  • Rork Gerald S. (Lawrence KS) Pipkin James D. (Lawrence KS)
출원인 / 주소
  • Merck & Co., Inc. (Rahway NJ 02)
인용정보 피인용 횟수 : 56  인용 특허 : 0

초록 ▼

A device is disclosed for the controlled delivery of a beneficial agent, the device consisting of (i) a core comprising at least two layers, wherein at least one layer comprises a beneficial agent and a polymer which forms microscopic gel beads upon hydration and at least one layer which comprises a

대표청구항 ▼

A drug delivery device for the controlled in situ production and release of a suspension containing a beneficial agent, consisting of: (a) a compressed core which comprises at least two layers, wherein at least one layer comprises an admixture of a therapeutically effective amount for those in need

이 특허를 인용한 특허 (56) 인용/피인용 타임라인 분석

  1. Kloke, Tim M.; Keough, Steven J.; Lockwood, Nathan; Gardner, Margaret R.; Hergenrother, Robert W.; Chappa, Ralph A., Beaded wound spacer device.
    상세보기
  2. Kim Cherng-ju, Coated tablet with long term parabolic and zero-order release kinetics.
    상세보기
  3. Kloke, Tim M.; Keough, Steven J.; Lockwood, Nathan; Gardner, Margaret R.; Hergenrother, Robert W.; Chappa, Ralph A., Coating composition.
    상세보기
  4. Sharma, Vinay K.; Hussain, Javed; Khorakiwala, Habil F., Composition for pulsatile delivery of diltiazem and process of manufacture.
    상세보기
  5. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
    상세보기
  6. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
    상세보기
  7. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
    상세보기
  8. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
    상세보기
  9. Ebert,Charles D.; Sanders,Steven W., Compositions and methods for transdermal oxybutynin therapy.
    상세보기
  10. Ebert,Charles D.; Sanders,Steven W., Compositions and methods for transdermal oxybutynin therapy.
    상세보기
  11. Kidane, Argaw, Compositions of quaternary ammonium compounds containing bioavailability enhancers.
    상세보기
  12. Cheng, Xiu Xiu; Qi, Xiaohong; Zhang, Guohua; Dixit, Manesh, Diltiazem controlled release formulation and method of manufacture.
    상세보기
  13. Lerner, E. Itzhak; Rosenberger, Vered; Aqua, Ofer; Fleshner Barak, Moshe, Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it.
    상세보기
  14. Chen Chih-Ming ; Chou Joseph ; Wong David, HMG co-reductase inhibitor.
    상세보기
  15. Chen, Chih-Ming; Chou, Joseph; Wong, David, HMG-CoA reductase inhibitor extended release formulation.
    상세보기
  16. MacGregor, Alexander, Hydrostatic delivery system for controlled delivery of agent.
    상세보기
  17. MacGregor,Alexander, Hydrostatic delivery system for controlled delivery of agent.
    상세보기
  18. Rodstrom, Theron Robert, Implantable drug delivery system.
    상세보기
  19. Moskowitz, Michael A.; Liao, James K.; Ron, Eyal S.; Omstead, Mary Nallin, Increasing cerebral bioavailability of drugs.
    상세보기
  20. Kidane, Argaw; Flanner, Henry H.; Bhatt, Padmanabh; Raoufinia, Arash, Method of treating bladder dysfunction with once-a-day trospium salt formulation.
    상세보기
  21. Geerke, Johan H.; Stone, Steven F., Methods and apparatus for determining formulation orientation of multi-layered pharmaceutical dosage forms.
    상세보기
  22. Geerke, Johan H; Stone, Steven F., Methods and apparatus for determining formulation orientation of multi-layered pharmaceutical dosage forms.
    상세보기
  23. Stone, Steven F.; Geerke, Johan H., Methods and apparatus for determining formulation orientation of multi-layered pharmaceutical dosage forms.
    상세보기
  24. Venkatesh, Gopi M.; Clevenger, James M., Modified release dosage forms of skeletal muscle relaxants.
    상세보기
  25. Venkatesh, Gopi M.; Clevenger, James M., Modified release dosage forms of skeletal muscle relaxants.
    상세보기
  26. Venkatesh, Gopi; Clevenger, James M., Modified release dosage forms of skeletal muscle relaxants.
    상세보기
  27. Venkatesh, Gopi; Clevenger, James M., Modified release dosage forms of skeletal muscle relaxants.
    상세보기
  28. Venkatesh, Gopi; Clevenger, James M., Modified release dosage forms of skeletal muscle relaxants.
    상세보기
  29. Venkatesh, Gopi; Clevenger, James M., Modified release dosage forms of skeletal muscle relaxants.
    상세보기
  30. Venkatesh, Gopi; Clevenger, James M., Modified release dosage forms of skeletal muscle relaxants.
    상세보기
  31. Venkatesh,Gopi; Clevenger,James M., Modified release dosage forms of skeletal muscle relaxants.
    상세보기
  32. Patrice Debregeas FR; Gerard Leduc FR; Pascal Oury FR; Pascal Suplie FR, Morphine sulfate microgranules, manufacturing process and pharmaceutical preparations.
    상세보기
  33. Chen Chih-Ming ; Chou Joseph C.H., Once daily calcium channel blocker tablet having a delayed release core.
    상세보기
  34. Kidane, Argaw; Flanner, Henry H.; Bhatt, Padmanabh; Raoufinia, Arash, Once daily dosage forms of trospium.
    상세보기
  35. Kidane, Argaw; Flanner, Henry H.; Bhatt, Padmanabh; Raoufinia, Arash, Once daily dosage forms of trospium.
    상세보기
  36. Chen Chih-Ming ; Chou Joseph C. H., Once daily pharmaceutical tablet having a unitary core.
    상세보기
  37. Chih-Ming Chen ; Joseph C. H. Chou, Once daily pharmaceutical tablet having a unitary core.
    상세보기
  38. Nogami, Eiji, Orally administered agent and an orally administered agent/supporting substrate complex.
    상세보기
  39. Shivanand Padmaja ; Hatamkhany Zahedeh ; Laidlaw Barbara F. ; Ayer Atul D., Phenytoin therapy.
    상세보기
  40. Sharma Vinay K., Process for the pulsatile delivery of diltiazem HCL and product produced thereby.
    상세보기
  41. Gelotte,Cathy Klech; Hills,Joanna F.; Pendley, II,Charles E.; Shah,Manoj N., Rapidly absorbed liquid compositions.
    상세보기
  42. Rinker, Roger A.; Casale, Nicholas J.; Comly, James H.; Pollock, Brenda; Ayer, Atul; Geerke, Johan; Costello, Martin; Wieand, Dennis; Parekh, Kishor, Rapidly disintegrating gelatinous coated tablets.
    상세보기
  43. Rinker, Roger A.; Casale, Nicholas J.; Comly, James H.; Pollock, Brenda; Ayer, Atul; Geerke, Johan; Costello, Martin; Wieand, Dennis; Parekh, Kishor, Rapidly disintegrating gelatinous coated tablets.
    상세보기
  44. Rinker, Roger A.; Casale, Nicholas J.; Comly, James H.; Pollock, Brenda; Ayer, Atul; Geerke, Johan; Costello, Martin; Wieand, Dennis; Parekh, Kishor, Rapidly disintegrating gelatinous coated tablets.
    상세보기
  45. Rinker, Roger A; Casale, Nicholas J.; Comly, James H.; Pollack, Brenda; Geerke, Johan; Costello, Martin; Wieand, Dennis; Parekh, Kishor, Rapidly disintegrating gelatinous coated tablets.
    상세보기
  46. Rinker, Roger A; Casale, Nicholas J.; Comly, James H.; Pollock, Brenda; Geerke, Johan; Costello, Martin; Wieand, Dennis; Parekh, Kishor, Rapidly disintegrating gelatinous coated tablets.
    상세보기
  47. Fox, Michael; Dorossiev, Ivo, Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids.
    상세보기
  48. Fox, Michael; Dorossiev, Ivo, Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids.
    상세보기
  49. Fox,Michael; Dorossiev,Ivo, Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids.
    상세보기
  50. Woo, Jong Soo; Yi, Hong-Gi; Chi, Moon-Hyuk; Ryu, Jae-Kuk; Jung, Si-Young; Kim, Yong-Il, Sustained release formulation for oral administration of HMG-CoA reductase inhibitor and method for the preparation thereof.
    상세보기
  51. Wells,David S.; Rajewski,Lian G.; Marriott,Thomas B.; Pipkin,James D.; Haslam,John L., Sustained-release formulations for treating CNS-mediated disorders.
    상세보기
  52. Kidane, Argaw; Flanner, Henry H.; Bhatt, Padmanabh; Raoufinia, Arash, Trospium chloride treatment method.
    상세보기
  53. Ebert, Charles D.; Sanders, Steven W., Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy.
    상세보기
  54. Fuller, Shawn; Claseman, Bryan A.; Slager, Joram; Missling, Jeffrey J.; Maharaj, Gary; Opperman, Gary W.; Lockwood, Nathan A.; Hergenrother, Robert W.; Olson, Charles, Wound packing device and method.
    상세보기
  55. Fuller, Shawn; Claseman, Bryan A.; Slager, Joram; Missling, Jeffrey J.; Maharaj, Gary; Opperman, Gary W.; Lockwood, Nathan; Hergenrother, Robert W.; Olson, Charles, Wound packing device and methods.
    상세보기
  56. Maharaj, Gary; Woodwick Sides, Teryl L., Wound packing device with nanotextured surface.
    상세보기

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 특허

해당 특허가 속한 카테고리에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로